Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.

Internet Explorer 10, Firefox, Chrome, or Safari.

BDC Capital provides mezz funding to venture-backed Nicoya

May 14, 2019 / Source: The PE Hub Network

BDC Capital has provided undisclosed mezzanine financing to Nicoya Lifesciences Inc, a Kitchener, Ontario-based nanotechnology company.

The funding is part of a $7.7 million investment in Nicoya that is also backed by FedDev Ontario.

BDC invested through its Growth & Transition Capital group. The transaction was led by Director Mark Lunick.

The funds raised will allow Nicoya to develop and market a new version of its flagship product, OpenSPR, a biosensor platform that supports biotechnology and pharmaceutical research applications, and meet demand.

Last year, Nicoya closed a $2 million financing led by Ripple Ventures and Golden Triangle Angel Network. BDC also invested in the round.

Read the full article here.